Changes in sexual problems over time in women with and without early-stage breast cancer

Menopause

Volumn 17, Issue 5, 2010, Pages 924-937

  Pérez, Maria ^a   Liu, Ying ^a   Schootman, Mario ^a,b   Aft, Rebecca L ^a,b,c   Schechtman, Kenneth B ^a,b   Gillanders, William E ^a,b   Jeffe, Donna B ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Ductal carcinoma in situ; Healthy comparison groups; Quality of life; Sexual problems

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; SEXUAL DYSFUNCTION; STRUCTURED INTERVIEW;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTERVIEWS AS TOPIC; MAMMOGRAPHY; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; QUALITY OF LIFE; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SURVIVORS;

EID: 77957692444     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181d5dd26     Document Type: Article

References (75)

1. Kornblith AB, Ligibel J. Psychosocial and sexual functioning of survivors of breast cancer. Semin Oncol 2003;30:799-813.
2. Ganz PA, Desmond KA, Belin TR, Meyerowitz BE, Rowland JH. Predictors of sexual health in women after breast cancer diagnosis. J Clin Oncol 1999;17:2371-2380.
3. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501-514.
4. Greendale G, Petersen L, Zibecchi L, Ganz P. Factors related to sexual function in postmenopausal women with a history of breast cancer. Menopause 2001;8:111-119.
5. Burwell SR, Case LD, Kaelin C, Avis NE. Sexual problems in younger women after breast cancer surgery. J Clin Oncol 2006;24:2815-2821.
6. Meyerowitz BE, Desmond KA, Rowland JH, Wyatt GE, Ganz PA. Sexuality following breast cancer. J Sex Marital Ther 1999;25:237-250.
7. Dorval M, Maunsell E, Deschenes L, Brisson J, Masse B. Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. J Clin Oncol 1998;16:487-494.
8. Ganz PA, Day R, Ware JE, Redmond C, Fisher B. Base-line quality of life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst 1995;87: 1372-1382.
9. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D. Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J 2004;10:223-231.
10. Schag CA, Ganz PA, Polinsky ML, et al. Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol 1993;11:783-793.
11. Schover LR, Yetman RJ, Tuason LJ, et al. Partial mastectomy and breast reconstruction. A comparison of their effects on psychosocial adjustment, body image, and sexuality. Cancer 1995;75:54-64.
12. Arora NK, Gustafson DH, Hawkins RP, et al. Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: a prospective study. Cancer 2001;92:1288-1298.
13. Ganz PA, Schag CA, Lee JJ, Polinsky ML, Tan SJ. Breast conservation versus mastectomy: is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 1992;69:1729-1738.
14. Ganz PA, Coscarelli A, Fred C, et al. Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat 1996;38:183-199.
15. Avis NE, Crawford S, Manuel J. Psychosocial problems among younger women with breast cancer. Psychooncology 2004;13:295-308.
16. Pozo C, Carver CS, Noriega V, et al. Effects of mastectomy versus lumpectomy on emotional adjustment to breast cancer: a prospective study of the first year postsurgery. J Clin Oncol 1992;10:1292-1298.
17. Rowland JH, Desmond KA, Meyerowitz BE, et al. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst 2000;92:1422-1429.
18. Yurek D, Farrar W, Andersen BL. Breast cancer surgery: comparing surgical groups and determining individual differences in postoperative sexuality and body change stress. J Consult Clin Psychol 2000;68: 697-709.
19. Parker PA, Youssef A, Walker S, et al. Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. Ann Surg Oncol 2007;14: 3078-3089.
20. Morrow M, Strom E, Bassett L, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002; 52:256-276. (Pubitemid 35345498)
21. Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19:2254-2262.
22. Ernster VL, Barclay J, Kerlikowske K, Wilki H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 2000;160:953-958.
23. Claus E, Petruzella S, Carter D, Kasl S. Quality of life for women diagnosed with breast carcinoma in situ. J Clin Oncol 2006;24:4875-4881.
24. Amichetti M, Caffo O, Arcicasa M, et al. Quality of life in patients with ductal carcinoma in situ of the breast treated with conservative surgery and postoperative irradiation. Breast Cancer Res Treat 1999;54: 109-115.
25. van Gestel YR, Voogd AC, Vingerhoets AJ, et al. A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer 2007; 43:549-556.
26. Syrjala KL, Schroeder TC, Abrams JR, et al. Sexual function measurement and outcomes in cancer survivors and matched controls. J Sex Res 2000;37:213-225.
27. Sherbourne CD. Social functioning: sexual problems measures. In: Stewart AL, Ware JE, eds. Measuring Functioning and Well-being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press, 1992:194-204.
28. Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women. Arch Sex Behav 1994;23:627-643.
29. Wapnir IL, Cody RP, Greco RS. Subtle differences in quality of life after breast cancer surgery. Ann Surg Oncol 1999;6:359-366.
30. Watts RJ. Sexual functioning, health beliefs, and compliance with high blood pressure medications. Nurs Res 1982;31:278-283.
31. Carrera C, Payne S. Ductal carcinoma in situ (DCIS) of the breast: the need for psychosocial research. Psychooncology 1999;8:538-545.
32. Leitch AM, Dodd GD, Costanza M, et al. American Cancer Society Guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin 1997;47:150-153.
33. Katzman R, Brown T, Fuld P, et al. Validation of a short Orientation-Memory-Concentration test of cognitive impairment. Am J Psychiatry 1983;140:734-739.
34. Brady MJ, Cella DF, Mo F, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality of life instrument. J Clin Oncol 1997;15:974-986. (Pubitemid 27106280)
35. Taylor KL, Lamdan RM, Siegel JE, et al. Treatment regimen, sexual attractiveness concerns and psychological adjustment among African American breast cancer patients. Psychooncology 2002;11:505-517.
36. Fobair P, Stewart SL, Chang S, et al. Body image and sexual problems in young women with breast cancer. Psychooncology 2006;15:579-594.
37. Schover LR. Sexuality and body image in younger women with breast cancer. J Natl Cancer Inst Monogr 1994;16:177-182.
38. Curran D, van Dongen JP, Aaronson NK, et al. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. Eur J Cancer 1998;34:307-314.
39. Beckjord E, Campas BE. Sexual quality of life in women with newly diagnosed breast cancer. J Psychosoc Oncol 2007;25:19-36.
40. Speer JJ, Hillenberg B, Sugrue DP, et al. Study of sexual functioning determinants in breast cancer survivors. Breast J 2005;11:440-447.
41. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
42. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56:893-897.
43. Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 1999;55:189-199.
44. Casso D, Buist DS, Taplin S. Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes 2004;2:25.
45. Broeckel JA, Thors CL, Jacobsen PB, Small M, Cox CE. Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat 2002;75:241-248.
46. Ganz PA, Greendale GA, Petersen L, et al. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst 2000;92:1054-1064.
47. Greendale GA, Hogan P, Shumaker S; for the Postmenopausal Estrogen/Progestin Interventions Trial (PEPI) Investigators. Sexual functioning in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Womens Health 1996;5:445-458. (Pubitemid 26394891)
48. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996;34:73-84.
49. Brandberg Y, Michelson H, Nilsson B, et al. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401. J Clin Oncol 2003;21:3659-3664.
50. Malinovszky KM, Gould A, Foster E, et al. Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. Br J Cancer 2006;95:1626-1631.
51. Mok K, Juraskova I, Friedlander M. The impact of aromatase inhibitors on sexual functioning: current knowledge and future research directions. Breast 2008;17:436-440.
52. Mourits MJ, Bockermann I, de Vries EG, et al. Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy. Br J Cancer 2002;86:1546-1550.
53. Day R. Quality of life and tamoxifen in a breast cancer prevention trial: a summary of findings from the NSABP P-1 study. Ann N Y Acad Sci 2001;949:143-150.
54. Fallowfield L, Fleissig A, Edwards R, et al. Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials. J Clin Oncol 2001;19:1885-1892.
55. Day R, Ganz PA, Costantino JP, et al. Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol 1999;17:2659-2669.
56. Lautenschlager GJ. A comparison of alternatives to conducting Monte Carlo analyses for determining parallel analysis criteria. Multivariate Behav Res 1989;24:365-395.
57. Hedeker D, Mermelstein RJ. Analysis of longitudinal substance use outcomes using ordinal random-effects regression models. Addiction 2000;95:S381-S394.
58. Liang KY, Zeger SL. Regression analysis for correlated data. Annu Rev Public Health 1993;14:43-68.
59. Huang GH, Palta M, Allen C, LeCaire T, D'Alessio D. Self-rated health among young people with type 1 diabetes in relation to risk factors in a longitudinal study. Am J Epidemiol 2004;159:364-372.
60. Sheu CF. Fitting mixed-effects models for repeated ordinal outcomes with the NLMIXED procedure. Behav Res Methods Instrum Comput 2002;34:151-157.
61. Schumacher S, McMillan JH. Research in Education, 3rd ed. New York: Harper Collins College Publishers, 1993.
62. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text rev. Washington, DC: American Psychiatric Association, 2000.
63. Quirk F, Haughie S, Symonds T. The use of the sexual function questionnaire as a screening tool for women with sexual dysfunction. J Sex Med 2005;2:469-477.
64. Schwartz GF, Solin LJ, Olivotto IA, et al. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. Cancer 2000;88:946-954.
65. Katz SJ, Lantz PM, Janz NK, et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol 2005;23:5526-5533.
66. Smitt MC, Heltzel M. Women's use of resources in decision-making for early-stage breast cancer: results of a community-based survey. Ann Surg Oncol 1997;4:564-569.
67. Kemeny MM, Wellisch DK, Schain WS. Psychosocial outcome in a randomized surgical trial for treatment of primary breast cancer. Cancer 1988;62:1231-1237.
68. Moyer A. Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review. Health Psychol 1997;16:284-293.
69. Schover LR. The impact of breast cancer on sexuality, body image, and intimate relationships. CA Cancer J Clin 1991;41:112-120.
70. Lindau ST, Schumm LP, Laumann EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med 2007; 357:762-774.
71. US Census Bureau. Census 2000 TIGER/Line Files Technical Documentation. Washington, DC: US Census Bureau, 2000.
72. Marcus AC, Garrett KM, Cella D, et al. Telephone counseling of breast cancer patients after treatment: a description of a randomized clinical trial. Psychooncology 1998;7:470-482.
73. Maguire KB. Does mode matter? A comparison of telephone, mail, and in-person treatments in contingent valuation surveys. J Environ Manage 2009;90:3528-3533.
74. Turner AN, De Kock AE, Meehan-Ritter A, et al. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews. J Clin Epidemiol 2009;62:759-765.
75. Kramer JR, Chan G, Kuperman S, et al. A comparison of diagnoses obtained from in-person and telephone interviews, using the Semi-structured Assessment for the Genetics of Alcoholism (SSAGA). J Stud Alcohol Drugs 2009;70:623-627.